Alertmeipp, No position, but am still following some biotechs out of general interest and for old time's sake. It's great to see Ampakines getting another chance.
We know that Ampakines upregulate respiratory drive from the previous Phase 2a trials, and with this new data the pharma world should finally take notice. Seeing the Dronabinol results will also be very interesting. Over the next 6 months we'll have a much better idea where this thing is headed.
News 
Market Data 
Discover 
